Mast cells are an essential hematopoietic component for polyp development
It is generally agreed that most colon cancers develop from adenomatous polyps, and it is this fact on which screening strategies are based. Although there is overwhelming evidence to link intrinsic genetic lesions with the formation of these preneoplastic lesions, recent data suggest that the tumor...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 104; no. 50; pp. 19977 - 19982 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
11.12.2007
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | It is generally agreed that most colon cancers develop from adenomatous polyps, and it is this fact on which screening strategies are based. Although there is overwhelming evidence to link intrinsic genetic lesions with the formation of these preneoplastic lesions, recent data suggest that the tumor stromal environment also plays an essential role in this disease. In particular, it has been suggested that CD34⁺ immature myeloid precursor cells are required for tumor development and invasion. Here we have used mice conditional for the stabilization of β-catenin or defective for the adenomatous polyposis coli (APC) gene to reinvestigated the identity and importance of tumor-infiltrating hematopoietic cells in polyposis. We show that, from the onset, polyps are infiltrated with proinflammatory mast cells (MC) and their precursors. Depletion of MC either pharmacologically or through the generation of chimeric mice with genetic lesions in MC development leads to a profound remission of existing polyps. Our data suggest that MC are an essential hematopoietic component for preneoplastic polyp development and are a novel target for therapeutic intervention. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Feature-3 ObjectType-Undefined-2 Edited by Lisa Coussens, University of San Francisco, San Francisco, CA, and accepted by the Editorial Board October 19, 2007 Author contributions: E.G. and S.E.E. contributed equally to this work; E.G., M.F.G., and K.K. designed research; E.G., S.E.E., C.R., D.S.F., F.G., G.Z., K.S., and K.K. performed research; S.E.E., M.F.G., D.S.F., F.G., D.M.L., J.N.G., K.S., V.P.R., T.P., R.W., and K.M.M. contributed new reagents/analytic tools; E.G., J.N.G., T.P., R.W., and K.K. analyzed data; and E.G., K.M.M., and K.K. wrote the paper. Present address: Department of Medicine/Gastroenterology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0704620104 |